tiprankstipranks
Trending News
More News >

Venus Medtech Announces Board Composition and Roles

Story Highlights
Venus Medtech Announces Board Composition and Roles

Don’t Miss TipRanks’ Half-Year Sale

Venus Medtech (Hangzhou), Inc. Class H ( (HK:2500) ) has issued an announcement.

Venus Medtech (Hangzhou) Inc. has announced the composition of its board of directors and their respective roles within various board committees. This update reflects the company’s commitment to strong corporate governance and strategic leadership, which is crucial for maintaining its competitive position in the medical technology sector.

More about Venus Medtech (Hangzhou), Inc. Class H

Venus Medtech (Hangzhou) Inc. is a joint stock company incorporated in the People’s Republic of China, operating within the medical technology industry. The company focuses on developing and providing innovative medical devices, particularly in the field of heart valve replacement and related cardiovascular solutions.

Average Trading Volume: 3,177,973

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$1.16B

Learn more about 2500 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1